Nanologica AB (publ) (STO:NICA)

Market Cap	35.79M -82.8%
Revenue (ttm)	22.65M +158.4%
Net Income	-47.51M
EPS	-0.56
Shares Out	88.37M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,792
Average Volume	230,409
Open	0.4100
Previous Close	0.4050
Day's Range	0.4010 - 0.4110
52-Week Range	0.3830 - 2.1700
Beta	-0.32
RSI	25.46
Earnings Date	Feb 12, 2026

About Nanologica AB

Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and pu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 19
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NICA

Financial Performance

In 2024, Nanologica AB's revenue was 14.54 million, an increase of 211.17% compared to the previous year's 4.67 million. Losses were -65.63 million, -12.68% less than in 2023.